{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:36:52Z","timestamp":1790714212427,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NHMRC Project Grant","award":["1100394"],"award-info":[{"award-number":["1100394"]}]},{"name":"ARC Discovery Project","award":["DP170103076"],"award-info":[{"award-number":["DP170103076"]}]},{"name":"Wellcome Trust Senior Fellow in Clinical Science","award":["200909"],"award-info":[{"award-number":["200909"]}]},{"name":"Australian NHMRC Senior Research Fellowship","award":["1104975"],"award-info":[{"award-number":["1104975"]}]},{"name":"Australian Centre for Research Excellence in Malaria Elimination","award":["1134989"],"award-info":[{"award-number":["1134989"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>An acute episode of malaria can be followed by multiple recurrent episodes either due to re-infection, recrudescence of a partially treated parasite or, in the case of <jats:italic>Plasmodium vivax<\/jats:italic> or <jats:italic>P. ovale<\/jats:italic>, relapse from the dormant liver stage of the parasite. The aim of this study was to quantify the impact of recurrent malaria episodes on morbidity and mortality in Papua, Indonesia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We undertook a retrospective analysis of routinely collected data from malaria patients attending the primary referral hospital in Papua, Indonesia, between April 2004 and December 2013. Multi-state modelling was used to estimate the effect of recurring malaria episodes on re-presentation and admission to hospital and death. The risks of early (\u2264\u200914\u2009days) and late (15 to 365\u2009days) hospital admission and death were estimated separately in our study to distinguish between the direct and indirect effects of malaria recurrence on adverse outcomes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 68,361 patients were included in the analysis, of whom 37,168 (54.4%) presented initially with <jats:italic>P. falciparum<\/jats:italic>, 22,209 (32.5%) with <jats:italic>P. vivax<\/jats:italic>, and 8984 (13.1%) with other species. During 12\u2009months of follow-up after each of the first four malaria episodes, 10,868 (15.9%) patients were admitted to hospital and 897 (1.3%) died. The risk of re-presenting to the hospital with malaria increased from 34.7% (95% CI 34.4%, 35.1%) at first episode to 58.6% (57.5%, 59.6%) following the third episode of malaria. After adjusting for co-factors, infection with <jats:italic>P. vivax<\/jats:italic> was a significant risk factor for re-presentation (hazard ratio (HR)\u2009=\u20091.48 (95% CI 1.44, 1.51)) and late admission to hospital (HR\u2009=\u20091.17 (1.11, 1.22)). Patients infected with <jats:italic>P. falciparum<\/jats:italic> had a greater overall rate of mortality within 14\u2009days (HR\u2009=\u20091.54 (1.25, 1.92)), but after multiple episodes of malaria<jats:italic>,<\/jats:italic> there was a trend towards a higher rate of early death in patients infected with <jats:italic>P. vivax<\/jats:italic> compared to <jats:italic>P. falciparum<\/jats:italic> (HR\u2009=\u20091.91 (0.73, 4.97)).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Compared to patients initially infected with <jats:italic>P. falciparum,<\/jats:italic> those infected with <jats:italic>P. vivax<\/jats:italic> had significantly more re-presentations to hospital with malaria, and this contributed to a high risk of inpatient admission and death. These findings highlight the importance of radical cure of <jats:italic>P. vivax<\/jats:italic> to eliminate the dormant liver stages that trigger relapses.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12916-020-1497-0","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:02:28Z","timestamp":1582164148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Saber","family":"Dini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne Rini","family":"Poespoprodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enny","family":"Kenangalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Sugiarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Plumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"key":"1497_CR1","volume-title":"World Malaria Report 2018","author":"World Health Organization (WHO)","year":"2016","unstructured":"World Health Organization (WHO). World Malaria Report 2018, vol. 2018. Geneva: World Health Organisation; 2016. doi: ISBN 978 92 4 1564403"},{"key":"1497_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12916-014-0217-z","volume":"12","author":"NM Douglas","year":"2014","unstructured":"Douglas NM, Pontororing GJ, Lampah DA, Yeo TW, Kenangalem E, Poespoprodjo JR, et al. Mortality attributable to Plasmodium vivaxmalaria: a clinical audit from Papua, Indonesia. BMC Med. 2014;12:217. https:\/\/doi.org\/10.1186\/s12916-014-0217-z.","journal-title":"BMC Med"},{"key":"1497_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002379","volume":"14","author":"NM Douglas","year":"2017","unstructured":"Douglas NM, Poespoprodjo JR, Patriani D, Malloy MJ, Kenangalem E, Sugiarto P, et al. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study. PLoS Med. 2017;14:e1002379. https:\/\/doi.org\/10.1371\/journal.pmed.1002379.","journal-title":"PLoS Med"},{"key":"1497_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005602","volume":"11","author":"A Devine","year":"2017","unstructured":"Devine A, Parmiter M, Chu CS, Bancone G, Nosten F, Price RN, et al. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: a cost-effectiveness analysis. PLoS Negl Trop Dis. 2017;11:e0005602. https:\/\/doi.org\/10.1371\/journal.pntd.0005602.","journal-title":"PLoS Negl Trop Dis"},{"key":"1497_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/QCO.0b013e32832f14c1","volume":"22","author":"RN Price","year":"2009","unstructured":"Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009;22:430\u20135. https:\/\/doi.org\/10.1097\/QCO.0b013e32832f14c1.","journal-title":"Curr Opin Infect Dis"},{"key":"1497_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050128","volume":"5","author":"E Tjitra","year":"2008","unstructured":"Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5:e128. https:\/\/doi.org\/10.1371\/journal.pmed.0050128.","journal-title":"PLoS Med"},{"key":"1497_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4269\/ajtmh.2003.68.416","volume":"68","author":"IW Sumawinata","year":"2003","unstructured":"Sumawinata IW, Bernadeta, Leksana B, Sutamihardja A, Purnomo, Subianto B, et al. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg. 2003;68:416\u201320. https:\/\/doi.org\/10.4269\/ajtmh.2003.68.416.","journal-title":"Am J Trop Med Hyg"},{"key":"1497_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.trstmh.2006.06.008","volume":"101","author":"A Ratcliff","year":"2007","unstructured":"Ratcliff A, Siswantoro H, Kenangalem E, Wuwung M, Brockman A, Edstein MD, et al. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine\u2013pyrimethamine in southern Papua, Indonesia. Trans R Soc Trop Med Hyg. 2007;101:351\u20139. https:\/\/doi.org\/10.1016\/j.trstmh.2006.06.008.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1497_CR9","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1186\/s12879-019-4497-y","volume":"19","author":"D Patriani","year":"2019","unstructured":"Patriani D, Arguni E, Kenangalem E, Dini S, Sugiarto P, Hasanuddin A, et al. Early and late mortality after malaria in young children in Papua, Indonesia. BMC Infect Dis. 2019;19:922. https:\/\/doi.org\/10.1186\/s12879-019-4497-y.","journal-title":"BMC Infect Dis"},{"key":"1497_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PMED.1002815","volume":"16","author":"E Kenangalem","year":"2019","unstructured":"Kenangalem E, Poespoprodjo JR, Douglas NM, Burdam FH, Gdeumana K, Chalfein F, et al. Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study. PLoS Med. 2019;16:e1002815. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1002815.","journal-title":"PLoS Med"},{"key":"1497_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1475-2875-7-148","volume":"7","author":"M Karyana","year":"2008","unstructured":"Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, Maristela R, et al. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J. 2008;7:148. https:\/\/doi.org\/10.1186\/1475-2875-7-148.","journal-title":"Malar J"},{"key":"1497_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(07)60160-3","volume":"369","author":"A Ratcliff","year":"2007","unstructured":"Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung R, Laihad F, et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet. 2007;369:757\u201365. https:\/\/doi.org\/10.1016\/S0140-6736(07)60160-3.","journal-title":"Lancet."},{"issue":"10","key":"1497_CR13","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/infdis\/jir558","volume":"204","author":"J. R. Poespoprodjo","year":"2011","unstructured":"Poespoprodjo JR, Fobia W, Kenangalem E, Hasanuddin A, Sugiarto P, Tjitra E, et al. Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission. J Infect Dis. 2011;204:1613\u20139. https:\/\/doi.org\/10.1093\/infdis\/jir558.","journal-title":"The Journal of Infectious Diseases"},{"key":"1497_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1191\/0962280202SM276ra","volume":"11","author":"PK Andersen","year":"2002","unstructured":"Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res. 2002;11:91\u2013115. https:\/\/doi.org\/10.1191\/0962280202SM276ra.","journal-title":"Stat Methods Med Res"},{"key":"1497_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/bimj.200510218","volume":"48","author":"H Putter","year":"2006","unstructured":"Putter H, van der Hage J, de Bock GH, Elgalta R, van de Velde CJH. Estimation and prediction in a multi-state model for breast cancer. Biom J. 2006;48:366\u201380. https:\/\/doi.org\/10.1002\/bimj.200510218.","journal-title":"Biom J"},{"key":"1497_CR16","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389\u2013430. https:\/\/doi.org\/10.1002\/sim.2712.","journal-title":"Stat Med"},{"key":"1497_CR17","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2019","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 2019. https:\/\/www.r-project.org\/."},{"key":"1497_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i07","volume":"38","author":"LC de Wreede","year":"2011","unstructured":"de Wreede LC, Fiocco M, Putter H. mstate : An R Package for the Analysis of Competing Risks and Multi-State Models. J Stat Softw. 2011;38:1\u201330. https:\/\/doi.org\/10.18637\/jss.v038.i07.","journal-title":"J Stat Softw"},{"key":"1497_CR19","volume-title":"A package for survival analysis in S","author":"TM Therneau","year":"2015","unstructured":"Therneau TM. A package for survival analysis in S. 2015. https:\/\/cran.r-project.org\/package=survival."},{"key":"1497_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001575","volume":"10","author":"NM Douglas","year":"2013","unstructured":"Douglas NM, Lampah DA, Kenangalem E, Simpson JA, Poespoprodjo JR, Sugiarto P, et al. Major burden of severe anemia from non-falciparum malaria species in southern Papua: a hospital-based surveillance study. PLoS Med. 2013;10:e1001575. https:\/\/doi.org\/10.1371\/journal.pmed.1001575.","journal-title":"PLoS Med"},{"key":"1497_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-397900-1.00003-7","volume":"80","author":"NM Anstey","year":"2012","unstructured":"Anstey NM, Douglas NM, Poespoprodjo JR, Price RN. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2012;80:151\u2013201. https:\/\/doi.org\/10.1016\/B978-0-12-397900-1.00003-7.","journal-title":"Adv Parasitol"},{"key":"1497_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1086\/512241","volume":"195","author":"M Imwong","year":"2007","unstructured":"Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195:927\u201333. https:\/\/doi.org\/10.1086\/512241.","journal-title":"J Infect Dis"},{"key":"1497_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/cid\/ciq249","volume":"52","author":"NM Douglas","year":"2011","unstructured":"Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, Singhasivanon P, et al. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis. 2011;52:612\u201320. https:\/\/doi.org\/10.1093\/cid\/ciq249.","journal-title":"Clin Infect Dis"},{"key":"1497_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1473-3099(10)70187-0","volume":"10","author":"F Smithuis","year":"2010","unstructured":"Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo APP, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis. 2010;10:673\u201381. https:\/\/doi.org\/10.1016\/S1473-3099(10)70187-0.","journal-title":"Lancet Infect Dis"},{"key":"1497_CR25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0140-6736(87)91479-6","volume":"2","author":"S Looareesuwan","year":"1987","unstructured":"Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T. High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet (London, England). 1987;2:1052\u20135. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2889965. Accessed 1 Jun 2019","journal-title":"Lancet (London, England)"},{"key":"1497_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1473-3099(18)30596-6","volume":"19","author":"RJ Commons","year":"2019","unstructured":"Commons RJ, Simpson JA, Thriemer K, Hossain MS, Douglas NM, Humphreys GS, et al. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19:91\u2013101. https:\/\/doi.org\/10.1016\/S1473-3099(18)30596-6.","journal-title":"Lancet Infect Dis"},{"key":"1497_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297. https:\/\/doi.org\/10.1186\/1475-2875-10-297.","journal-title":"Malar J"},{"key":"1497_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1475-2875-11-135","volume":"11","author":"NM Douglas","year":"2012","unstructured":"Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, et al. The anaemia of Plasmodium vivax malaria. Malar J. 2012;11:135. https:\/\/doi.org\/10.1186\/1475-2875-11-135.","journal-title":"Malar J"},{"key":"1497_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/tropej\/fmi069","volume":"52","author":"AJ Rodr\u00edguez-Morales","year":"2006","unstructured":"Rodr\u00edguez-Morales AJ, S\u00e1nchez E, Vargas M, Piccolo C, Colina R, Arria M. Anemia and thrombocytopenia in children with Plasmodium vivax malaria. J Trop Pediatr. 2006;52:49\u201351. https:\/\/doi.org\/10.1093\/tropej\/fmi069.","journal-title":"J Trop Pediatr"},{"key":"1497_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0169-4758(00)01774-9","volume":"16","author":"C Menendez","year":"2000","unstructured":"Menendez C, Fleming AF, Alonso PL. Malaria-related Anaemia. Parasitol Today. 2000;16:469\u201376. https:\/\/doi.org\/10.1016\/S0169-4758(00)01774-9.","journal-title":"Parasitol Today"},{"key":"1497_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/J.PT.2009.02.003","volume":"25","author":"NM Anstey","year":"2009","unstructured":"Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol. 2009;25:220\u20137. https:\/\/doi.org\/10.1016\/J.PT.2009.02.003.","journal-title":"Trends Parasitol"},{"key":"1497_CR32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/qjmed\/90.12.751","volume":"90","author":"TN Williams","year":"1997","unstructured":"Williams TN, Maitland K, Phelps L, Bennett S, Peto TEA, Viji J, et al. Plasmodium vivax: a cause of malnutrition in young children. QJM. 1997;90:751\u20137. https:\/\/doi.org\/10.1093\/qjmed\/90.12.751.","journal-title":"QJM."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-1497-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-1497-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-1497-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T18:37:19Z","timestamp":1613846239000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-1497-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-1497-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,20]]},"assertion":[{"value":"12 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data used in this work were provided by previous published studies that acquired proper ethical approval from relevant organisations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}